Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B London

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
Journal of the American Academy of Dermatology|December 1, 2023
Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter studyElena B Hawryluk, Danna Moustafa, Kelly K Barry, et al.
American Journal of Hematology|February 12, 2020
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiencyPaola Bianchi, Elisa Fermo, Kimberly Lezon-Geyda, et al.
Neuro-Oncology|July 31, 2024
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patientsMary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, et al.
Nature|December 3, 2010
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneKai Wang, Sharon J Diskin, Haitao Zhang, et al.
Journal of the National Cancer Institute|March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma PatientsPauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
The Lancet. Oncology|June 12, 2009
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyJoëlle Vermeulen, Katleen De Preter, Arlene Naranjo, et al.
Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Journal of the American Academy of Dermatology|December 1, 2023
Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter studyElena B Hawryluk, Danna Moustafa, Kelly K Barry, et al.
American Journal of Hematology|February 12, 2020
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiencyPaola Bianchi, Elisa Fermo, Kimberly Lezon-Geyda, et al.
Neuro-Oncology|July 31, 2024
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patientsMary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, et al.
Nature|December 3, 2010
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneKai Wang, Sharon J Diskin, Haitao Zhang, et al.
Journal of the National Cancer Institute|March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma PatientsPauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
The Lancet. Oncology|June 12, 2009
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyJoëlle Vermeulen, Katleen De Preter, Arlene Naranjo, et al.
Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Pageof 29